Increased incidence of mild cognitive impairment in long COVID patients
INTRODUCTION
Though brain fog is common in Long-coronavirus disease 2019 (Long-COVID), the incidence of mild cognitive impairment (MCI) is unknown.
METHODS
In an observational cohort study, recovered COVID-positive, Long-COVID, and COVID-negative subjects underwent blinded evaluation using National Alzheimers Coordinating Center (NACC) and National Institute on Aging (NIA) -Alzheimers Association diagnostic criteria for dementia and MCI. The cumulative incidence of MCI was calculated for each group, and the hazard of MCI was compared between groups.
RESULTS
Among 260 subjects, the cumulative incidence of MCI over 4.4 years was higher with Long-COVID (27%) versus recovered-COVID (5%) or COVID-negative status (1%). There was a higher hazard of MCI for patients with Long-COVID compared to those without (hazard ratio
3.93, 95% confidence interval [CI] 1.86–8.31, p < 0.001), and specifically for the Alzheimers disease (AD) -related MCI subtype (HR 3.20, 95% confidence interval [CI] 1.14–9.00, p = 0.027).
DISCUSSION
The cumulative incidence and adjusted hazard of MCI (and specifically AD-related MCI) at 4.4 years was significantly higher among Long-COVID patients compared to recovered-COVID and COVID-negative controls.
HIGHLIGHTS
The cumulative incidence of mild cognitive impairment (MCI) was higher in Long-coronavirus disease 2019 (Long-COVID) compared to other groups.
The hazard of MCI was four-fold higher for Long-COVID subjects.
The hazard of Alzheimers disease related MCI was significantly higher with Long-COVID.
The hazard of MCI due to psychiatric illness did not differ between groups.
Web | DOI | PDF | Alzheimer's & Dementia | Open Access
Jennifer A Frontera; Arjun V Masurkar; Rebecca A Betensky; Zariya Alvarez; Allal Boutajangout; Joshua Chodosh; Salma Hammam; Jessica Hunter; Li Jiang; Melanie Li; Jon Links; Karyn Marsh; Huize Pang; Floyd Silva; Sujata Thawani; Daria Vasilchenko; Alok Vedvyas; Amin Yakubov; Yulin Ge; Thomas Wisniewski
INTRODUCTION
Though brain fog is common in Long-coronavirus disease 2019 (Long-COVID), the incidence of mild cognitive impairment (MCI) is unknown.
METHODS
In an observational cohort study, recovered COVID-positive, Long-COVID, and COVID-negative subjects underwent blinded evaluation using National Alzheimers Coordinating Center (NACC) and National Institute on Aging (NIA) -Alzheimers Association diagnostic criteria for dementia and MCI. The cumulative incidence of MCI was calculated for each group, and the hazard of MCI was compared between groups.
RESULTS
Among 260 subjects, the cumulative incidence of MCI over 4.4 years was higher with Long-COVID (27%) versus recovered-COVID (5%) or COVID-negative status (1%). There was a higher hazard of MCI for patients with Long-COVID compared to those without (hazard ratio
3.93, 95% confidence interval [CI] 1.86–8.31, p < 0.001), and specifically for the Alzheimers disease (AD) -related MCI subtype (HR 3.20, 95% confidence interval [CI] 1.14–9.00, p = 0.027).
DISCUSSION
The cumulative incidence and adjusted hazard of MCI (and specifically AD-related MCI) at 4.4 years was significantly higher among Long-COVID patients compared to recovered-COVID and COVID-negative controls.
HIGHLIGHTS
The cumulative incidence of mild cognitive impairment (MCI) was higher in Long-coronavirus disease 2019 (Long-COVID) compared to other groups.
The hazard of MCI was four-fold higher for Long-COVID subjects.
The hazard of Alzheimers disease related MCI was significantly higher with Long-COVID.
The hazard of MCI due to psychiatric illness did not differ between groups.
Web | DOI | PDF | Alzheimer's & Dementia | Open Access